A. Visvikis

Genetic Variation in the Vascular Endothelial Growth Factor (VEGFA) Gene at rs13207351 Is Associated with Overall Survival of Patients with Head and Neck Cancer

A. Psyrri, K. Papadopoulou, G. Fountzilas, 2021, Cancers.

Genetic Variations of VEGFA Gene Are Associated With Infiltration of Adjacent Tissues and the Clinical Outcome of Patients With Nasopharyngeal Carcinoma

J. Constantinidis, D. Rontogianni, K. Papadopoulou, 2020, AntiCancer Research.

Investigation of prognostic biomarkers in patients with urothelial carcinoma treated with platinum-based regimens.

F. Fostira, A. Charchanti, A. Psyrri, 2022, Urologic oncology.

Tumor Genotyping and Homologous Recombination Repair Gene Variants in Patients With Epithelial Ovarian Cancer: Is Pathogenic Enough?

F. Fostira, E. Giannoulatou, G. Aravantinos, 2021, Frontiers in Oncology.

Posterior Reversible Encephalopathy Syndrome With Concurrent Nephrotic Syndrome in a Patient Treated With Pazopanib for Metastatic Renal Cell Carcinoma: Case Report and Review of the Literature

G. Papaxoinis, E. Samantas, A. Visvikis, 2017, Clinical genitourinary cancer.

Incidence of Disease Recurrence in Patients With Colon and Upper Rectum Adenocarcinoma Stage II and III Receiving Adjuvant Capecitabine Monotherapy: Do Number of Chemotherapy Cycles and Relative Dose Intensity of the Drug Play a Role?

G. Aravantinos, N. Dessypris, D. Mauri, 2023, Clinical colorectal cancer.

Patterns of practice and pharmacoeconomic analysis of the management of patients with metastatic renal cell carcinoma (mRCC) in Greece––the CRISIS study. A retrospective analysis by the Hellenic Genitourinary Cancer Group (HGUCG)

M. Dimopoulos, A. Papatsoris, G. Aravantinos, 2018, Expert review of pharmacoeconomics & outcomes research.

Investigation of Clinically Significant Molecular Aberrations in Patients with Prostate Cancer: Implications for Personalized Treatment, Prognosis and Genetic Testing

D. Giannakis, I. Boukovinas, A. Psyrri, 2023, International journal of molecular sciences.